Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02515162
Other study ID # CONE-2
Secondary ID
Status Completed
Phase N/A
First received July 28, 2015
Last updated August 13, 2016
Start date July 2015
Est. completion date August 2016

Study information

Verified date August 2016
Source Zydolab - Institute of Cytology and Immune Cytochemistry
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

In a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, two electrosurgical excision methods, Fischer Cone Biopsy Excison vs. Loop Excision Procedure, will be compared. The primary outcome of the study is dysplasia-free resection margin rate, secondary outcomes are intraoperative blood loss, time to complete hemostasis, intervention time, postoperative pain, intra- and postoperative complications, the resected cone volume and users satisfaction.


Description:

Conization is the method of choice in therapy for cervical dysplasia. Beside the risk of preterm delivery, the risk of a local relapse in patients with dysplasia-affected resection margin is high.

The Goldstandard standard technique in conization for women with cervical dysplasia is the large loop excision of the transformation zone ("LLETZ"). Nevertheless other techniques such as the excision of the abnormal tissue with the so called "Fischer Cone Biopsy Excisor" could provide advantages and is yet not enough investigated. The loop excision technique uses a circular electrode, in contrast Fischer Cone Biopsy Excision is done by a triangular electrode.

It is unknown, whether the use of the circular or the triangular electrode is superior regarding the dysplasia-free resection margin rate and other outcome parameters such as the resected cone volume, postoperative bleeding and postoperative pain. Therefore, the investigator designed a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, comparing the two electrosurgical techniques, "LLETZ-conization" and "Fischer Cone Biopsy Excision". The primary outcome of the study is the dysplasia-free resection margin rate independently proved by a pathologist, secondary outcomes are intraoperative blood loss measured as difference in serum hemoglobin pre- and postoperatively, postoperative pain according to a 11 step VAS scale, time to complete hemostasis measured in seconds, duration of the intervention measured in minutes, resected cone volume, users satisfaction according to a 11 step VAS scale and intra- and postoperative complications, defined as necessity to intervene surgically up to 14 days postoperatively.

The study Population consists of women undergoing conization for histologically proven cervical dysplasia.


Recruitment information / eligibility

Status Completed
Enrollment 178
Est. completion date August 2016
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- histologically proven cervical dysplasia

- colposcopy Prior to conization

- informed consent

- no known hematologic disorder

Exclusion Criteria:

- significant language barrier

- a personal history of conization

- pregnancy

- the use of blood thinner

- unwillingness to participate

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Intervention

Procedure:
Fischer Cone Biopsy Excisor
Electrosurgical excision method using a triangular electrode to remove the abnormal cervical Transformation zone
Loop Excision Procedure
Electrosurgical excision method using a circular electrode to remove the abnormal cervical Transformation zone

Locations

Country Name City State
Germany Department of Obstetrics and Gynecology of the Ruhr University Bochum Herne NRW

Sponsors (2)

Lead Sponsor Collaborator
Zydolab - Institute of Cytology and Immune Cytochemistry Ruhr University of Bochum

Country where clinical trial is conducted

Germany, 

References & Publications (6)

Bevis KS, Biggio JR. Cervical conization and the risk of preterm delivery. Am J Obstet Gynecol. 2011 Jul;205(1):19-27. doi: 10.1016/j.ajog.2011.01.003. Epub 2011 Feb 23. Review. — View Citation

Boardman LA, Steinhoff MM, Shackelton R, Weitzen S, Crowthers L. A randomized trial of the Fischer cone biopsy excisor and loop electrosurgical excision procedure. Obstet Gynecol. 2004 Oct;104(4):745-50. — View Citation

Jin G, LanLan Z, Li C, Dan Z. Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis. Arch Gynecol Obstet. 2014 Jan;289(1):85-99. doi: 10.1007/s00404-013-2955-0. Epub 2013 Jul 11. Review. — View Citation

Khalid S, Dimitriou E, Conroy R, Paraskevaidis E, Kyrgiou M, Harrity C, Arbyn M, Prendiville W. The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG. 2012 May;119(6):685-91. doi: 10.1111/j.1471-0528.2011.03252.x. Epub 2012 Feb 14. — View Citation

Mathevet P, Chemali E, Roy M, Dargent D. Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP. Eur J Obstet Gynecol Reprod Biol. 2003 Feb 10;106(2):214-8. — View Citation

Shaco-Levy R, Eger G, Dreiher J, Benharroch D, Meirovitz M. Positive margin status in uterine cervix cone specimens is associated with persistent/recurrent high-grade dysplasia. Int J Gynecol Pathol. 2014 Jan;33(1):83-8. doi: 10.1097/PGP.0b013e3182763158. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Margin status Resection margin is judge as "R0" if abnormal cells are not found in the margin of the biopsy or "R1" if abnormal cells remain in the margin of the biopsy. The histopathological examination will be done by an Independent pathologist 2 Days after conization No
Secondary Intraoperative blood loss intraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively 5 hours No
Secondary Postoperative pain patients will score their postoperative pain Level using a 11-step visual analogue scale (nVAS) and a 5-step graphical visual analogue scale (gVAS)within 5 hours after surgery 5 hours No
Secondary Time to complete intraoperative hemostasis the time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds 120 seconds No
Secondary Operation time the time from the beginning of the Operation (start of the electrosurgical method) until the end of the operation (the end of hemostatic interventions) will be measured in minutes 20 minutes No
Secondary Resected cone volume The resected cone volume will be measured postoperative by using a scale 10 minutes No
Secondary satisfaction with the device surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,satisfaction with the device' (ranging from 0 (,very satisfied') to 10 (,absolutely not satisfied') 30 minutes No
Secondary handling of the device surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,(ranging from 0 (,very easy') to 10 (,very difficult') 30 minutes No
Secondary Operative complications Operative complications defined as necessity to intervene surgically up to 14 days postoperatively 14 days Yes
Secondary number of fragments of the surgical specimen surgeons will count the number of the surgical specimen (1 vs. >1) 10 minutes No
See also
  Status Clinical Trial Phase
Completed NCT01505920 - Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Phase 3
Completed NCT01014026 - Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Phase 3
Completed NCT00377845 - Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear. Phase 0
Completed NCT02910388 - LLETZ Under Direct Colposcopic Vision N/A
Completed NCT00596258 - A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) Phase 2
Completed NCT03763565 - Effectiveness of HPV Vaccine in Thai Adult Women
Completed NCT04415840 - Lugol's Solution in Addition to Acetic Acid During Colposcopy
Recruiting NCT04783805 - Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Completed NCT04326049 - LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy N/A
Completed NCT02486471 - Hemostatic Procedure After Biopsy of the Cervix N/A
Completed NCT01405768 - Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) Phase 2
Completed NCT00264732 - A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Phase 2/Phase 3
Completed NCT03296566 - The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams N/A
Completed NCT02346227 - Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Phase 3
Completed NCT02330471 - Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Phase 3
Completed NCT01035580 - Trial on Safety and Pharmacokinetics of Intravaginal Curcumin Phase 1
Completed NCT01639820 - Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts N/A
Completed NCT00285207 - Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix Phase 2
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care
Completed NCT01034358 - Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Phase 4